Beyond cancer: The potential application of CD47-based therapy in non-cancer diseases
CD47 is an immune checkpoint widely regarded as a ‘don't eat me’ signal. CD47-based anti-cancer therapy has received considerable attention, with a significant number of clinical trials conducted. While anti-cancer therapies based on CD47 remain a focal point of interest among researchers, it i...
| Published in: | Acta Pharmaceutica Sinica B |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383524004519 |
